Enter assignee name

Forward Citations = 2

Loading Chart...

14 inventors (with patents filed for the assignee):

Cheng-Lun Ku (4 out of 4 patents)

Hung-Kai Chen (3 out of 12 patents)

Han-Po Shih (3 out of 3 patents)

4. Jing-Ya Ding (3 out of 3 patents)

5. Jing-Yi Huang (3 out of 13 patents)

6. Daw-Tsun Shih (2 out of 2 patents)

7. Huey-Wen Hsiao (2 out of 2 patents)

8. Chia-Hao Lin (2 out of 7 patents)

9. Yi-Ting Kuo (2 out of 2 patents)

10. Pei-Han Chung (2 out of 2 patents)

11. Chih-Lun Hsiao (1 out of 2 patents)

12. Hong-Sen Chen (1 out of 10 patents)

13. Yu-Fang Lo (1 out of 1 patent)

14. Yin-Ping Wang (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12398205 - Anti-interferon gamma antibodies and uses thereof (2025-08-26),

2. 12291567 - Antibodies to granulocyte-macrophage colony stimulating factor and uses thereof (2025-05-06),

3. 11773167 - Anti-PD-L1 antibodies and anti-PD-L1/IL10 fusion proteins (2023-10-03),

4. 11396549 - Anti-colony stimulating factor 1 receptor (CSF1R) antibodies and methods of use thereof for treating cancer (2022-07-26),

5. 10968274 - Anti-interferon gamma antibodies and uses thereof (2021-04-06),

6. 10813974 - Methods for treatment of HBV infection (2020-10-27),

Elixiron Immunotherapeutics (Hong Kong) Limited is a biotechnology company dedicated to developing innovative immunotherapies for cancer treatment. With a focus on precision medicine and personalized therapy, Elixiron aims to revolutionize cancer care through the discovery and development of novel immune-oncology medicines. Our team of experienced researchers and scientists work tirelessly to bring cutting-edge treatments to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#494 in Hong Kong

#3,857 in China

Hong Kong, China

Elixiron Immunotherapeutics (hong Kong) Limited